Errors made in the design and conduct of a clinical trial can make it impossible for the trial to provide a definitive answer about the effectiveness of a new approach. Poor design can thus lead to the abandonment of promising avenues of research that are based on sound basic scientific work and to delays in the introduction of new treatments into the general practice of medical oncology. ECCO, AACR, EORTC and ESMO have responded to this problem by designing jointly a programme that will:
Download Programme